Internal Server Error

About CDH

CDH is a private equity firm founded in 2002. It is primarily based in Kowloon, China. As of Oct 2026, CDH is an active investor with a portfolio of 324 companies, comprising 324 funding rounds and 6 acquisitions. In the last 12 months, it has participated in 16 funding rounds. The firm primarily invests in companies based in China and United States. Its portfolio is spread across a wide range of sectors from High Tech to Life Sciences. Its latest investment was a $***** Series B round in Vast3D on Sep 01, 2026 which also saw participation from Matrix Partners China, BlueFocus and other investors. 
Overall CDH portfolio has seen 13 unicorns, 60 IPOs and 19 acquisitions including key companies like Ceva, Qihoo 360 Technology and TuSimple. A lot of funds co-invest with CDH, with names like Hillhouse sharing a substantial percentage of its portfolio. 
CDH has a team of 109 people, including 44 partners.
Key Metrics
Founded Year
2002
Location
Kowloon, China
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals

CDH's Portfolio

CDH has a portfolio of 324 companies. They have invested in a total of 324 companies. Their most recent investment was in Vast3D (Series B round) on Sep 01, 2026. Here are the most recent investments by CDH:
Date
Company
Round
Amount
Co-Investors
Sep 01, 2026
Series B
5091
Aug 19, 2026
Series C
9301
Jul 10, 2026
Angel
1410
Jul 08, 2026
Series A
5580
CDH has acquired 6 companies. Their most recent acquisition was of WOW Tech on Feb 27, 2020. Here are the most recent acquisitions by CDH:
Acquisition Date
Company
Short Description
Total Funding
Founded Year
Feb 27, 2020
Designer and manufacturer of intimate pleasure products. It designs, manufactures, and markets a portfolio of brands offering a variety of sexual wellness products. These products utilize innovative technologies and designs to enhance intimacy and pleasure. The company collaborates with sexual wellness experts throughout the product development process, ensuring products are both effective and safe. The company's focus is on creating high-quality products that meet diverse needs and preferences.
-
2018
Jun 14, 2018
Developer of radiation therapy for the treatment of cancer
-
1991
Jun 07, 2017
Specialty biopharma company that develops and commercializes specialist-oriented drugs
-
1989
Feb 05, 2021
Provider of construction management services
-
1999
Here is the portfolio snapshot of CDH:
Investments by Year
The maximum number of investments were made in 2021
Investments by Year - The maximum number of investments were made in 2021# Investments20262024202220202018Year
Acquisitions by Year
The maximum number of acquisitions were made in 2020
Acquisitions by Year - The maximum number of acquisitions were made in 2020# Acquisitions20262024202220202018Year
Portfolio by Location
Companies are primarily in China and United States
Portfolio by LocationChinaUnited States
Portfolio by Sector
Companies are primarily in High Tech
Portfolio by SectorHigh TechLife Sciences

Team profile of CDH

CDH has a team of 109 members including 44 Partners and 23 Principals located in China, Singapore and 4 more locations. CDH's team sits on the board of 1 company.
Here is a list of top team members in CDH:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Singapore
-
Partner
San Francisco
-
Partner
Hong Kong
-
Partner
Hong Kong
-
Partner
China
-
Partner
Hong Kong
-
-
Partner
Shanghai
-
Partner
Beijing
-
Partner
China
-
Partner
Shanghai
-
Partner
Shanghai
-

Co-investors of CDH

Over the past 24 years, 378 investors have co-invested in CDH's portfolio companies.

  • Top Co-investors of CDH: 378 investors entered a company along with CDH. These include investors like Hillhouse (7 companies).

CDH News

View more CDH News

FAQs about CDH

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford